当前位置:首页 - 行情中心 - 贝达药业(300558) - 财务分析

贝达药业

(300558)

  

流通市值:200.72亿  总市值:201.36亿
流通股本:4.19亿   总股本:4.21亿

贝达药业(300558)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.03亿元,每股收益0.76元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益591956.14万元,未分配利润285788.29万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产969946.26万元,负债377990.12万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,717,342,723.911,731,412,742.27917,554,506.922,891,950,112.03
营业总成本2,301,749,460.621,494,357,686.84730,520,724.152,460,400,758.66
其他经营收益
营业利润394,491,937.66188,147,769.79123,067,237.11399,871,684.57
利润总额391,574,046.96187,816,069.23123,152,668.55394,158,101.64
净利润303,006,092.01130,707,401.195,463,516.48386,979,402.58
每股收益
其他综合收益43,432,024.6-148,106,979.63-137,880,994.1556,915,948.89
综合收益总额346,438,116.61-17,399,578.53-42,417,477.67443,895,351.47
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,484,177,061.951,358,719,685.231,301,717,893.561,224,330,599.97
非流动资产:
非流动资产合计8,215,285,574.757,840,648,525.127,823,800,408.48,117,347,123.84
资产总计9,699,462,636.79,199,368,210.359,125,518,301.969,341,677,723.81
流动负债:
流动负债合计1,927,160,477.241,756,546,635.12,092,412,147.121,847,959,887.48
非流动负债:
非流动负债合计1,852,740,722.271,765,342,827.011,401,806,555.711,827,607,601.77
负债合计3,779,901,199.513,521,889,462.113,494,218,702.833,675,567,489.25
所有者权益(或股东权益):
归属于母公司股东权益合计5,843,399,746.135,594,364,394.565,543,677,139.015,573,806,060.13
股东权益合计5,919,561,437.195,677,478,748.245,631,299,599.135,666,110,234.56
负债和股东权益合计9,699,462,636.79,199,368,210.359,125,518,301.969,341,677,723.81
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,737,853,928.251,818,979,709.29968,760,882.263,219,792,591
经营活动现金流出小计2,069,423,681.331,374,001,421.08671,225,194.252,308,620,414.78
经营活动产生的现金流量净额668,430,246.92444,978,288.21297,535,688.01911,172,176.22
投资活动产生的现金流量:
投资活动现金流入小计1,013,509.4214,509.42100,00031,722,710.16
投资活动现金流出小计731,485,187.19391,306,234.66192,857,786.751,033,415,672.65
投资活动产生的现金流量净额-730,471,677.77-391,291,725.24-192,757,786.75-1,001,692,962.49
筹资活动产生的现金流量:
筹资活动现金流入小计809,946,278672,166,278150,000,000644,750,000
筹资活动现金流出小计807,159,708.6670,150,013.23178,190,846.43836,133,783.9
筹资活动产生的现金流量净额2,786,569.42,016,264.77-28,190,846.43-191,383,783.9
汇率变动对现金及现金等价物的影响1,901,864.44-196,210.48-133,207.851,590,510.79
现金及现金等价物净增加额-57,352,997.0155,506,617.2676,453,846.98-280,314,059.38
期末现金及现金等价物余额414,329,858.11527,189,472.38548,136,702.1471,682,855.12
补充资料:
现金及现金等价物的净增加额-55,506,617.26--280,314,059.38
最新报告期:2025-11-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
兴业证券孙媛媛,杨希成,黄翰漾1.401.772.142025-11-30
西部证券李梦园1.361.712.042025-11-04
华安证券谭国超1.391.752.132025-10-31
国投证券连国强1.211.742.202025-10-30
TOP↑